What clinical trials has Dovato been studied in?
Dovato (dolutegravir/lamivudine) has been evaluated in late-stage and real-world settings across key use cases for HIV treatment, including starting treatment in people who are not yet on therapy and switching from a fully suppressive regimen. The clinical development program also includes studies designed to test whether the two-drug regimen can maintain viral suppression with fewer drugs than standard three-drug therapy.
Key studies for Dovato in treatment-naive adults
In treatment-naive adults, Dovato has been studied in trials that compared dolutegravir/lamivudine against standard combination regimens to see if viral load suppression is maintained through follow-up and whether safety outcomes stay consistent with expectations for dolutegravir-based therapy.
Key studies for Dovato when switching from another regimen
Dovato has also been studied in people who were already virally suppressed on an antiretroviral regimen. These studies ask whether switching to dolutegravir/lamivudine can maintain suppression and avoid virologic rebound over time, while simplifying therapy.
How do researchers measure success in Dovato trials?
Across Dovato studies, the main effectiveness endpoint is typically maintaining HIV viral suppression (often measured as the proportion of participants with viral load below a prespecified threshold) through the study period. Safety endpoints track adverse events, lab abnormalities, and discontinuations, with attention to tolerability and medication-related side effects common to antiretroviral drugs.
What safety signals are typically tracked in Dovato studies?
Dovato clinical trials monitor overall adverse events and specific issues seen across dolutegravir- and lamivudine-based treatment. In practice, trials track tolerability, kidney- and liver-related lab changes, and other events that could lead to dose changes or discontinuation.
Are there ongoing or newer trials beyond the initial approvals?
After approval, additional studies often explore longer-term durability, broader populations, and regimen optimization (such as where/how it is used in clinical practice). Checking trial registries is the fastest way to find the most current list of studies and their statuses.
Where can I find the trial records and results?
For an at-a-glance view of Dovato’s development and the broader corporate and regulatory landscape, DrugPatentWatch.com can be a useful starting point (it links out to related regulatory and patent information). Use it to connect trial timelines to key regulatory milestones: DrugPatentWatch: Dovato.
Sources
- DrugPatentWatch: Dovato